First Insight into a Nationwide Genotypic Diversity of<i> Mycobacterium tuberculosis</i> among Previously Treated Pulmonary Tuberculosis Cases in Benin, West Africa

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Type of resistance</td><td class="align_center">MDR strains<br/><i>n</i> = 9<br/><i>n</i> (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Susceptible to all second-line drugs</td><td class="align_center">6 (66.7)</td></tr><tr><td class="align_left">Monoresistance</td><td class="align_center"> </td></tr><tr><td class="align_left"> Ofloxacin</td><td class="align_center">2 (22.2)</td></tr><tr><td class="align_left"> Kanamycin</td><td class="align_center">1 (11.1)</td></tr><tr><td class="align_left"> Capreomycin</td><td class="align_center">0</td></tr><tr><td class="align_left"> Amikacin</td><td class="align_center">0</td></tr><tr><td class="align_left">Total</td><td class="align_center"><i>3 (33.3)</i></td></tr><tr><td class="align_left">XDR</td><td class="align_center">0</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>XDR: extensively drug-resistant.<br/></td></tr></table>

Resistance patterns to second-line drugs on MDR strains.

Canadian Journal of Infectious Diseases and Medical Microbiology

tab2

Table 2

Table 2: First Insight into a Nationwide Genotypic Diversity of<i> Mycobacterium tuberculosis</i> among Previously Treated Pulmonary Tuberculosis Cases in Benin, West Africa 

Table 2 | First Insight into a Nationwide Genotypic Diversity of Mycobacterium tuberculosis among Previously Treated Pulmonary Tuberculosis Cases in Benin, West Africa 